The 8th Diabetes and Ramadan International Alliance Conference: January 23–24, 2020, Dubai, United Arab Emirates

Sami Kenz; Hussam Abusahmin; Akrem Elmalti; Salem Beshyah

doi:10.4103/ijmbs.ijmbs_8_20

Ibnosina Journal of Medicine and Biomedical Sciences, Table of Contents

CC BY-NC-ND 4.0 · Ibnosina Journal of Medicine and Biomedical Sciences 2020; 12(01): 62-67
DOI: 10.4103/ijmbs.ijmbs_8_20

Conference Highlights

The 8^th Diabetes and Ramadan International Alliance Conference: January 23–24, 2020, Dubai, United Arab Emirates

Sami Kenz

¹Rashid Center for Diabetes and Research, Ajman

,

Hussam Abusahmin

²Department of Endocrinology, Al Qassimi Hospital, Sharjah

,

Akrem Elmalti

¹Rashid Center for Diabetes and Research, Ajman

,

Salem Beshyah

³Department of Endocrinology, Mediclinic Airport Road Hospital, Abu Dhabi

⁴Department of Medicine, Dubai Medical College, Dubai

› Author Affiliations

Abstract

The 8^th Ramadan and Diabetes International Alliance Annual Conference was held over 2 days on January 24^th and 25^th in Dubai, United Arab Emirates. The program included six sessions in total. The three states of the art lectures addressed (a) an overview of the current knowledge on insulin therapy during Ramadan, (b) journey of diabetes from EPIDIAR, to CREED and ending by DAR-MENA-T2DM, and (c) feasibility and management of fasting after bariatric surgery. Sessions on the 1^st day considered four themes spanning from the impact of Ramadan on physical and mental well-being, efficacy and safety of newer antidiabetic medications during Ramadan, adherence to medications for diabetes and hypothyroidism, and the safety of Ramadan fasting in high-risk groups (cardiovascular and renal). The 2^nd day started with a session on bridging the gap between physicians and religious scholars, including a live question and answer session “ask the imam.” The rest of the sessions covered management of type 1 diabetes during Ramadan, patients and doctors perceptions of fasting from various regions and finally a scientific session on nutrition and weight management during Ramadan. RaD activities seem to develop progressively in variety and quality of content and also far-reaching audiences and participants.

Key-words:

Diabetes - ethnicity - fasting - hyperglycemia - hypoglycemia - Muslims - Ramadan - safety

Full Text

References

References
1 Beshyah SA. Fasting during the month of Ramadan for people with diabetes: Medicine and Fiqh United at last. Ibnosina J Med B S 2009;1:58-60.
2 Sherif IH, Lakhdar AA. Ramadan fasting and the medical patient: Consensus is welcome but more evidence is needed. Ibnosina J Med Biomed Sci 2010;2:237-9.
3 Khalil AB, Lakhdar AA, Benbarka MM, Sherif IH. Research and Ramadan fasting: Not too much of a good thing. Ibnosina J Med Biomed Sci 2018;10:35-6.
4 Diabetes and Ramadan International Alliance. Home Page. Available from: https://www.daralliance.org/daralliance/. [Last accessed 2020 Jan 02].
5 Beshyah SA. IDF-DAR practical guidelines for the management of diabetes during Ramadan. Ibnosina J Med BS 2016;8:58-60.
6 Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004;27:2306-11.
7 Babineaux SM, Toaima D, Boye KS, Zagar A, Tahbaz A, Jabbar A, et al. Multi-country retrospective observational study of the management and outcomes of patients with type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med 2015;32:819-28.
8 Hassanein M, Al Awadi FF, El Hadidy KE, Ali SS, Echtay A, Djaballah K, et al. The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM). Diabetes Res Clin Pract 2019;151:275-84.
9 Al-Ozairi E, Al Kandari J, AlHaqqan D, AlHarbi O, Masters Y, Syed AA. Obesity surgery and Ramadan: A prospective analysis of nutritional intake, hunger and satiety and adaptive behaviours during fasting. Obes Surg 2015;25:523-9.
10 Azar ST, Echtay A, Wan Bebakar WM, Al Araj S, Berrah A, Omar M, et al. Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): A randomized trial. Diabetes Obes Metab 2016;18:1025-33.
11 Hassanein MM, Sahay R, Hafidh K, Djaballah K, Li H, Azar S, et al. Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial. Diabetes Res Clin Pract 2019;150:331-41.
12 Bouida W, Baccouche H, Sassi M, Dridi Z, Chakroun T, Hellara I, et al. Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel. Thromb J 2017;15:15.
13 Beltaief K, Bouida W, Trabelsi I, Baccouche H, Sassi M, Dridi Z, et al. Metabolic effects of Ramadan fasting in patients at high risk of cardiovascular diseases. Int J Gen Med 2019;12:247-54.
14 Sassi M, Chakroun T, Chouchène S, Hellara I, Boubaker H, Grissa MH, et al. Does Lipid profile affect thrombin generation during Ramadan fasting in patients with cardiovascular risks? Clin Appl Thromb Hemost 2017;23:980-6.
15 Alamoudi R, Alsubaiee M, Alqarni A, Aljaser S, Saleh Y, Salam A, et al. Attitudes and habits of patients with type 1 diabetes during fasting Ramadan. J Clin Transl Endocrinol 2018;14:1-4.